FDA Drugs (New Approvals & NDA)Original article
Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
RegulatoryNeutral
AI Analysis
Summary
The FDA issues Non-Compliance letters under PREA to sponsors who have failed to submit required pediatric assessments or obtain deferrals by the final due date.
Outcome Details
FDA PREA Non-Compliance letter requirements under 505B(d)(1) for sponsors who failed to submit pediatric assessments by final due date or failed to seek/obtain deferral
Importance:3/10
Sentiment:
0.00
PREAPediatric AssessmentFDA ComplianceRegulatoryNon-Compliance
Read the original article
Published by FDA Drugs (New Approvals & NDA) on October 6, 2026 3:05 PM